Zannat Kawser has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic performance of discriminant formulas and machine learning models for detecting β-thalassemia trait in Bangladesh

    by Rumana Mahtarin, Kasrina Azad, Rakib Bin Mahbub Talukder, Rynak Rahmat, Suzana Chowdhury Nitu, Arif Mahmud Howlader, Mohabbat Hossain, Mst. Sharmin Aktar Mukta, Mohammad Tanbir Habib, Abu Bakar Siddik, et al.

    Background: β-thalassemia poses a considerable public health burden in Bangladesh, where a high carrier frequency underlies widespread disease risk. It is necessary to distinguish β-thalassemia trait (βTT) and iron deficiency anemia (IDA) to ensure genetic counseling and enable effective prevention strategies. Despite the availability of various discriminant formulas and machine learning algorithms (MLAs), their comparative diagnostic performance within the Bangladeshi population has not been comprehensively investigated. This study aimed to assess different discriminant formulas and ML models as well as to propose novel combinations of formulas for population-specific screening of βTT. Methods: In this cross-sectional study, we compared 47 discriminant formulas and 12 machine learning models to distinguish β-thalassemia trait from iron-deficiency anemia in 467 individuals (143 βTT, 324 anemia) drawn from a 2,514-participant cohort. DF-6 and DF-27 were two new formulas constructed by integrating high-performing formulas. Multi-criteria decision-making (MCDM) techniques, TOPSIS (Technique for Order Preference by Similarity to Ideal Solution) and SECA (Simultaneous Evaluation of Criteria and Alternatives), provided the final ranking for performance. Cluster analysis was performed to identify groups with similar diagnostic performance. Results: Population-specific optimal cut-off values were determined for the discriminant formulas. The newly proposed formulas, DF-6 and DF-27, ranked among the top ten performers alongside RBC, Janel (11T), Ravanbakhsh-F1, Srivastav, Alparslan, Hisham, Index 26, and Kerman I. DF-6 (AUC: 0.9707) achieved the best overall performance across the diagnostic metrics. DF-6 achieved the best overall performance (AUC: 0.98, 95% CI: 0.97–0.99, p < 0.0001). Assessment of ML models revealed that XGBoost (XGB) (AUC: 0.98, 95% CI: 0.97–0.99, p < 0.0001) and Support Vector Machine (SVM) (AUC: 0.97, 95% CI: 0.95–0.99, p < 0.0001) provided the highest diagnostic accuracy. The reliability of ensemble ML models was confirmed by MCDM and cluster analyses. Conclusions: The combination of novel discriminant formula DF-6 and integration of XGB and SVM ML models can substantially strengthen nationwide screening programs to reduce the burden of thalassemia in Bangladesh.

  • Open Access

    Clinical and genomic characterization of Klebsiella pneumoniae infections in Dhaka, Bangladesh

    by Zannat Kawser, Sushmita Sridhar, Sanchita Kar, Tanbir Habib, Sharmin Akter Mukta, Kasrina Azad, Neyamul Hasan, Umme Kulsum, Abu Bakar Siddik, Saikt Rahman, et al.


  • Open Access

    SARS-CoV-2 variant survey: Comparison of RT-PCR screening with TGS and variant distribution across two divisions of Bangladesh

    by Zannat Kawser, Saikt Rahman, Emilie Westeel, Mohammad Tanbir Habib, Mohabbat Hossain, Rakibul Hassan Bulbul, Sharmin Aktar Mukta, Zahirul Islam, Zakir Hossain, Mokibul Hassan Afrad, et al.

    Background: The widespread increase in multiple variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) since 2020 is causing significant health concerns worldwide. While whole-genome sequencing (WGS) has played a leading role in surveillance programs, many local laboratories lack the expertise and resources. Thus, we aimed to investigate the circulating SARS-CoV-2 variants and evaluate the performance of multiplexed real-time reverse transcription-PCR (RT-PCR) for screening and monitoring the emergence of new SARS-CoV-2 variants in Bangladesh. Methods: A total of 600 confirmed SARS-CoV-2-positive cases were enrolled either prospectively or retrospectively from two divisions of Bangladesh. The samples were screened by variant RT-PCR targeting five mutations of the spike gene (N501Y, P681R, L452R, E484K, E484Q). A subsample of the study population was also selected for third-generation sequencing (TGS) and the results were compared to the variant RT-PCR screening. An in-depth comparison was made between the two methods in terms of congruence and cost-benefit. Result: Seven variants were detected among samples, with similar distributions of the variants across both divisions. Variant RT-PCR for the targeted mutations lead to a 98.5% call rate; only nine samples failed to be determined. No association was found regarding the demographic features, clinical criteria, or routine RT-PCR Ct values across the variants. The clade diversity of the sequenced subpopulation (n = 99) exhibited similar distributions across the two study sites and other epidemiologic variables. Variant RT-PCR successfully distinguished variants of concern (VOCs) and variants of interest (VOIs); however, 8% discrepancy was observed for the closest lineages. Moreover, the variant RT-PCR represented an ideal balance of cost, time, and accuracy that outweigh their limitations. Conclusion: Based on the strong agreement of variant RT-PCR with TGS, such rapid, easily accessible approaches of rapid strain typing are essential in the context of pandemic responses to guide both treatment decisions and public health measures.


  • Open Access

    Pharmacokinetic and safety analysis of biosimilar adalimumab in healthy volunteers in Bangladesh

    by Umme Kulsum, Kasrina Azad, Mubasshir Washif, Mohabbat Hossain, Nishat Sultana, Ismail Hossain, Faez Ahmed, Ridwanur Rahman, Abdul Muktadir, Hasneen Muktadir, et al.


  • Open Access

    Pharmacokinetic and safety analysis of biosimilar adalimumab in healthy volunteers in Bangladesh

    by Umme Kulsum, Kasrina Azad, Mubasshir Washif, Mohabbat Hossain, Nishat Sultana, Ismail Hossain, Faez Ahmed, Ridwanur Rahman, Abdul Muktadir, Hasneen Muktadir, et al.

    Aims Advixa is a monoclonal antibody manufactured as a biosimilar to adalimumab (Humira, Abbvie Inc.). The key objectives of this study were to use a healthy population group to assess pharmacokinetics (PK) and safety similarity between Advixa and Humira in healthy participants and to quantify the effects of potential covariates on adalimumab PK and safety to assess the impact of treatment with Advixa. Methods A group of healthy participants selected by screening aged between 18 and 45 years. According to the randomization table, each participant was given Adalimumab (Advixa and Humira) in the inpatient facilities in a hospital and observed for 72 hours. Several blood samples were collected from the participants at different time points up to day 64 to measure their Pharmacokinetics and biosimilarity. Results The serum concentration-time profiles for PK and safety were compared in this randomized, double-blinded study between Humira and Advixa. A review of the data for biosimilarity confirmed that these products are similar to each other regarding healthy participants. 90% confidence interval of the relative mean Cmax, AUC0-t, and AUCo-inf of the Advixa and Humira were found within the acceptance criteria. No differences in safety profiles were observed in these studies. Conclusion PK and safety are similar between Advixa and Humira in participants with healthy status demonstrated in this clinical trial (NCT05172817; Registration Date/Initial Release Date: 28/09/2021). Adalimumab PK was also similar to treatment with Humira and Advixa.

  • Open Access

    An Assessment of a Rapid SARS-CoV-2 Antigen Test in Bangladesh

    by Zannat Kawser, Mohabbat Hossain, Sara Suliman, Shahin Lockman, Jesse Gitaka, Gama Bandawe, Redwan Rahmat, Imrul Hasan, Abu Bakar Siddik, Mokibul Hassan Afrad, et al.

    Early detection of SARS-CoV-2 infection is crucial to prevent its spread. This study aimed to document test sensitivity/specificity, correlation with cycle threshold value from polymerase chain reaction (PCR), fitness-for-use in different populations and settings, and user perspectives that could inform large-scale implementation. In this study, we evaluated the performance of a rapid antigen detection test, BD Veritor, and compared this (and another rapid test, Standard Q) against reverse transcription PCR (RT-PCR) in terms of sensitivity and specificity in 130 symptomatic and 130 asymptomatic adults. In addition, we evaluated the suitability and ease of use of the BD Veritor test in a subsample of study participants (n = 42) and implementers (n = 5). At 95% confidence interval, the sensitivity of the BD Veritor and Standard Q test were 70% and 63% in symptomatic and 87% and 73% in asymptomatic individuals, respectively, regarding positive SARS-CoV-2 RT-PCR results. Overall, the BD Veritor test was 78% sensitive and 99.5% specific compared with RT-PCR irrespective of the cycle threshold. This warrants large field evaluation as well as use of the rapid antigen test for quick assessment of SARS-CoV-2 for containment of epidemics in the country.


  • Open Access

    Association of Virulence with Antimicrobial Resistance among Klebsiella pneumoniae Isolated from Hospital Settings in Bangladesh

    by Zannat Kawser, S. M. Shamsuzzaman

    Introduction: Infections caused by multidrug-resistant (MDR) hypervirulent Klebsiella pneumoniae are difficult to treat and associated with high mortality rates. Hence, this study was conducted to determine the antibiotic resistance pattern along with the distribution of virulence genes among isolated string test positive and negative strains. Materials and Methods: A total of 44 K. pneumoniae strains were isolated following standard microbiological methods from 350 different clinical samples from patients admitted to Dhaka Medical College Hospital, Bangladesh. String test was done to detect the hypermucoid phenotype. Antimicrobial resistance (AMR) pattern was determined by dichlorodiphenyltrichloroethane (except colistin and fosfomycin) among all isolates. Polymerase chain reaction was done to detect the hypervirulence genes (magA, rmpA, rmpA2 iutA, iroN). Results: In this study, 21/44 (47.73%) of the isolated K. pneumoniae were string test positive and distribution of the virulence genes except rmpA2 was higher among them. A total of 15/44 (34.09%) of the isolated K. pneumoniae were MDR, 10/44 (22.73%) were extensively drug resistant, 1/44 (2.27%) was pan drug resistant, and 14/44 (31.82%) were colistin resistant. Isolated organisms were highly resistant to third-generation cephalosporins and most sensitive to fosfomycin in this study. Although all the string test positive strains showed higher resistance rates than the string test negative ones toward most of the tested antibiotics, only the differences of resistance rates to amoxiclav and tigecycline among the two phenotypes were statistically significant. Conclusion: Our findings highlight the importance of surveillance of the AMR pattern of hypervirulent K. pneumoniae in clinical samples. Therefore, a response to check the global dissemination of this hypervirulent K. pneumoniae with resistance determinants is urgently needed.


  • Open Access

    Assessment of performance and implementation characteristics of rapid point of care SARS-CoV-2 antigen testing

    by Eva Muthamia, Samuel Mungai, Mary Mungai, Gama Bandawe, Firdausi Qadri, Zannat Kawser, Shahin Lockman, Louise C Ivers, David Walt, Sara Suliman, et al.

    Background: The COVID-19 pandemic has resulted in a need for rapid identification of infectious cases. Testing barriers have prohibited adequate screening for SARS-CoV-2, resulting in significant delays in commencement of treatment and outbreak control measures. This study aimed to generate evidence on the performance and implementation characteristics of the BD Veritor™ Plus System rapid antigen test as compared to reverse transcription polymerase chain reaction (RT-PCR) for diagnosis of SARS-CoV-2 in Kenya. Methods: This was a field test performance evaluation in adults undergoing testing for SARS-CoV-2. Recruited participants were classified as SARS-CoV-2-positive based on RT-PCR carried out on nasopharyngeal swabs. Antigen tests were performed with simultaneous RT-PCR on 272 participants, allowing estimation of sensitivity, specificity, positive and negative predictive values for the rapid antigen test. Implementation characteristics were assessed. Results: We enrolled 97 PCR negative symptomatic and 128 PCR negative asymptomatic, and 28 PCR positive symptomatic and 19 PCR positive asymptomatic participants. Compared to RT-PCR, the sensitivity of the rapid antigen test was 94% (95% confidence interval [CI] 86.6 to 100.0) while the specificity was 98% (95% CI 96 to 100). There was no association between sensitivity and symptom status, or between the cycle threshold value and sensitivity of the BD Veritor. The rapid test had a quick turnaround time, required minimal resources, and laboratory personnel conducting testing found it easier to use than RT-PCR. The relatively high sensitivity of BD Veritor may be partially attributed to shortages of RT-PCR testing materials, resulting in specimen analysis delays and potential degradation of viral genetic material. Therefore, in resource-constrained settings, rapid antigen tests may perform better than the reference RT-PCR, resulting in prompt institution of isolation and treatment measures. Conclusion: The BD Veritor rapid antigen test’s high sensitivity should be interpreted with consideration to the challenges occasioned by RT-PCR testing in resource-constrained settings.


  • Open Access

    An assessment of a rapid SARS-CoV-2 antigen test in Bangladesh

    by Zannat Kawser, Mohabbat Hossain, Sara Suliman, Shahin Lockman, Jesse Gitaka, Gama Bandawe, Redwan Rahmat, Imrul Hasan, Abu Bakar Siddik, Mokibul Hassan Afrad, et al.

    Early detection of SARS-CoV-2 infection is crucial to prevent the spread of the virus. In this study, we evaluated the performance of a commercial rapid antigen detection test, BD Veritor, and compared this (and another rapid test, Standard Q) against a gold-standard of nasopharyngeal (NP) swab tested by reverse transcription-polymerase chain reaction (RT-PCR) in prospectively-recruited adults in Dhaka, Bangladesh. We compared the sensitivity and specificity of the two rapid antigen tests against RT-PCR results in 130 symptomatic and 130 asymptomatic adults. In addition, we evaluated the suitability and ease-of-use of the BD Veritor test in a subsample of study participants (n=42) and implementers (n=5). The sensitivity of the BD Veritor rapid antigen test was 70% in symptomatic (95% confidence interval [CI]: 51-85%) and 87% (95% CI: 69-96%) in asymptomatic individuals with positive SARSCoV-2 RT-PCR, for overall sensitivity of 78% (95% CI: 66-88%). The sensitivity of the Standard Q rapid antigen test was 63% (95% CI: 44-80%) in symptomatic and 73% (95% CI: 54-87%) in asymptomatic individuals. One false positive in BD Veritor test (specificity 99.5) and no false positive in Standard Q tests were observed (specificity 100%). The BD Veritor rapid antigen test was 78% sensitive when compared with RT-PCR irrespective of the cycle threshold (Ct) levels in this evaluation in Bangladesh. The implementation evaluation data showed good acceptability in the field settings. This warrants large field evaluation as well as use of the rapid antigen test for quick assessment of SARS-CoV-2 for containment of epidemics in the country.


  • Open Access

    Intradermal Immunization with Heat-Killed Klebsiella pneumoniae Leading to the Production of Protective Immunoglobulin G in BALB/c Mice

    by Zannat Kawser, Sm Shamsuzzaman

    To determine the protective efficacy of antibodies elicited by killed vaccine against multidrug-resistant (MDR) K. pneumoniae. Materials and Methods: In this study, heat-killed MDR K. pneumoniae isolated from different clinical samples were employed for the intradermal immunization of 10 BALB/c mice. Two weeks after the third dose of immunization, the mice were intraperitoneally challenged with live K. pneumoniae and observed for 14 days. Tail blood was collected 7 days after each booster followed by cardiac puncture 14 days postchallenge. Bactericidal activity and antigen-binding capacity of the serum antibody produced by the vaccine were evaluated by serum bactericidal antibody (SBA) assay and ELISA, respectively. Results: In this study, 80% survival rates were observed at 14 days postchallenge among the immunized mice. Regarding SBA assay, 100% bactericidal activity of the immunized mouse sera was observed using 50% guinea pig complement at 1:10 serum dilution after 3 h of incubation, and all the pre- and postchallenge immunized serum immunoglobulin G antibody had significantly higher optical density values comparing the control mice in ELISA. Conclusion: In our study, intradermal immunization with heat-killed MDR K. pneumoniae produced protective antibodies in BALB/c mice. These findings suggest that the use of a first-generation vaccine provides the supply of a larger number of candidate antigens for eliciting required immune response....